Evogene Q4 EPS $(0.13) Beats $(0.14) Estimate, Sales $578.00K Beat $500.00K Estimate
Evogene Q4 EPS $(0.13) Beats $(0.14) Estimate, Sales $578.00K Beat $500.00K Estimate
Evogene第四季度每股收益美元（0.13美元）超過預期（0.14美元），銷售額578.00萬美元超過預期的500.00萬美元
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 85.71 percent decrease over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $578.00 thousand.
Evogene（納斯達克股票代碼：EVGN）公佈的季度虧損爲每股0.13美元，比分析師普遍預期的0.14美元（0.14美元）高出7.14％。這比去年同期每股虧損0.07美元（0.07）下降了85.71％。該公司公佈的季度銷售額爲57.8萬美元。